The syntheses of rac-inthomycin A, (+)-inthomycin B and (+)-inthomycin C using a unified synthetic approach

Tetrahedron

Volumn 64, Issue 21, 2008, Pages 4778-4791

  Webb, Michael R ^a   Addie, Matthew S ^a   Crawforth, Catherine M ^a   Dale, James W ^a   Franci, Xavier ^a   Pizzonero, Mathieu ^a   Donald, Craig ^b   Taylor, Richard J K ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAL DERIVATIVE; AMINO ACID DERIVATIVE; INTHOMYCIN A; INTHOMYCIN B; INTHOMYCIN C; NATURAL PRODUCT; OXAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CATALYSIS; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROLYSIS; ISOMERIZATION; MUKAIYAMA REACTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STILL GENNARI REACTION; STILLE REACTION; STREPTOMYCES; STRUCTURE ANALYSIS;

STREPTOMYCES;

EID: 42249110694     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.01.116     Document Type: Article

References (64)

1. Mori T., Takahashi K., Kashiwabara M., Uemura D., Katayama C., Iwadare S., Shizuri Y., Mitomo R., Nakano F., and Matsuzaki A. Tetrahedron Lett. 26 (1985) 1073-1076
2. Tonew E., Tonew M., Grafe U., and Zopel P. Acta Virol. 36 (1992) 166-172
3. Kanzaki H., Wada K., Nitoda T., and Kawazu K. Biosci. Biotechnol. Biochem. 62 (1998) 438-442
4. Takahashi K., Kawabata M., Uemura D., Iwadare S., Mitomo R., Nakano F., and Matsuzaki A. Tetrahedron Lett. 26 (1985) 1077-1078
5. Ogura M., Nakayama H., Furihata K., Shimazu A., Seto H., and Otake N. J. Antibiot. 38 (1985) 669-673
6. Ogura M., Nakayama H., Furihata K., Shimazu A., Seto H., and Otake N. Agric. Biol. Chem. 49 (1985) 1909-1910
7. Ryu G., Hwang S., and Kim S.-K. J. Antibiot. 50 (1997) 1064-1066
8. Ryu G., and Kim S.-K. J. Antibiot. 52 (1999) 193-197
9. Otani T., Yoshida K.-I., Kubota H., Kawai S., Ito S., Hori H., Ishiyama T., and Oki T. J. Antibiot. 53 (2000) 1397-1400
10. Manam R.R., Teisan T., White D.J., Nicholson B., Grodberg J., Neuteboom S.T.C., Lam K.S., Mosca D.A., Lloyd G.K., and Potts B.C.M. J. Nat. Prod. 68 (2005) 240-243
11. For a review covering the isolation, structure determination, biological properties and synthetic approaches to the oxazolomycins, see:. Moloney M.G., Trippier P.C., Yaqoob M., and Wang Z. Curr. Drug Discov. Technol. 1 (2004) 181-199
12. For our earlier work on the spirocyclic pyrrolidinone portion of the oxazolomycins, see:. Papillon J.P.N., and Taylor R.J.K. Org. Lett. 2 (2000) 1987-1990
13. Taylor R.J.K., and Papillon J.P.N. Abstr. Pap. Am. Chem. Soc. 222 (August 2001) 379
14. Papillon J.P.N., and Taylor R.J.K. Org. Lett. 4 (2002) 119-122
15. For other synthetic approaches to the spirocyclic pyrrolidinone portion of the oxazolomycins, see Ref. 18 and. Andrews M.D., Brewster A.G., and Moloney M.G. Synlett (1996) 612-614
16. Moloney M.G., and Yaqoob M. Synlett (2004) 1631-1633
17. Mohapatra D.K., Mondal D., Gonnade R.G., Chorghade M.S., and Gurjar M.K. Tetrahedron Lett. 47 (2006) 6031-6035
18. Donohoe T.J., Chiu J.Y.K., and Thomas R.E. Org. Lett. 9 (2007) 421-424
19. Bennett N.J., Prodger J.C., and Pattenden G. Tetrahedron 63 (2007) 6216-6231
20. Omura S., Tanaka Y., Kanaya I., Shinose M., and Takahashi Y. J. Antibiot. 43 (1990) 1034-1036
21. Tanaka Y., Kanaya I., Shiomi K., Tanaka H., and Omura S. J. Antibiot. 46 (1993) 1214-1218
22. Henkel T., and Zeeck A. Liebigs Ann. Chem. (1991) 367-373
23. Shiomi K., Arai N., Shinose M., Takahashi Y., Yoshida H., Iwabuchi J., Tanaka Y., and Omura S. J. Antibiot. 48 (1995) 714-719
24. Gräfe U., Kluge H., and Thiericke R. Liebigs Ann. Chem. (1992) 429-432
25. Tanaka Y., Kanaya I., Takahashi Y., Shinose M., Tanaka H., and Omura S. J. Antibiot. 46 (1993) 1208-1213
26. Omura S. Gene 115 (1992) 141-149
27. Legrende F., Maturano M.D., Etienne G., Klaebe A., and Tiraby G. J. Antibiot. 48 (1995) 341-343
28. Kawada M., Yoshimoto Y., Minamiguchi K., Kumagai H., Someno T., Masuda T., Ishizuka M., and Ikeda D. Anticancer Res. 24 (2004) 1561-1568
29. Hénaff N., and Whiting A. Org. Lett. 1 (1999) 1137-1139
30. Hénaff N., and Whiting A. Tetrahedron 56 (2000) 5193-5204
31. Kende A.S., Kawamura K., and DeVita R.J. J. Am. Chem. Soc. 112 (1990) 4070-4072
32. Kawamura K., DeVita R.J., and Kende A.S. J. Syn. Org. Chem. Jpn. 50 (1992) 61-70
33. Note added in proof: after the submission of this paper a second synthesis of neooxazolomycin was reported (. Onyango E.O., Tsurumoto J., Imai N., Takahashi K., Ishihara J., and Hatakeyama S. Angew. Chem., Int. Ed. 46 (2007) 6703-6705 )
34. Bulger P.G., Moloney M.G., and Trippier P.C. Synlett (2002) 1871-1873
35. Bulger P.G., Moloney M.G., and Trippier P.C. Org. Biomol. Chem. 1 (2003) 3726-3737
36. Addie M.S., and Taylor R.J.K. J. Chem. Soc., Perkin Trans. 1 (2000) 527-531
37. For reviews see:
38. Bach T. Angew. Chem., Int. Ed. Engl. 33 (1994) 417-419
39. Carreira E.M. In: Jacobsen E.N., Pfaltz A., and Yamamoto H. (Eds). Comprehensive Asymmetric Catalysis Vol. 3 (1999), Springer, Heidelberg 998
40. Kiyooka S.-I., Kaneko Y., Komura M., Matsuo H., and Nakano M. J. Org. Chem. 56 (1991) 2276-2278
41. Kiyooka S.-I. Rev. Heteroat. Chem. 17 (1997) 245-270
42. Fujiyama R., Goh K., and Kiyooka S.-I. Tetrahedron Lett. 46 (2005) 1211-1215 and references therein
43. see also:. Imashiro R., and Kuroda T. J. Org. Chem. 68 (2003) 974-979
44. Webb M.R., Donald C., and Taylor R.J.K. Tetrahedron Lett. 47 (2006) 549-552
45. van Leusen A.M., Hoogenboom B.E., and Siderius H. Tetrahedron Lett. 13 (1972) 2369-2372
46. Renaldo A.F., Labadie J.W., and Stille J.K. Org. Synth. 67 (1988) 86-93 (also commercially available)
47. Wender P.A., Sieburth S.McN., Petraitis J.J., and Singh S.K. Tetrahedron 37 (1981) 3967-3975
48. Still W.C., and Gennari C. Tetrahedron Lett. 24 (1983) 4405-4408
49. Ando K. Tetrahedron Lett. 36 (1995) 4105-4108
50. These model studies were based on the following transformation:
51. {A figure is presented}The R- and S- enantiomers of I were separated using HPLC with a Daicel Chiralcel OD column, eluting with 9:1 hexane-isopropanol. Variation of solvent, stoichiometry of reagents, times and temperatures gave ee's in the range 53-84% (with yields generally in the 80-90% range). The optimum ee was obtained using the l-valine-derived oxazaborolidinone 25a (84% ee) but the l-phenylalanine-derived oxazaborolidinone 25b was also effective giving I in 82% ee.
52. Copper thiophene carboxylate-induced coupling (. Allred G.D., and Liebeskind L.S. J. Am. Chem. Soc. 118 (1996) 2748-2749 ) was investigated to avoid the presence of palladium. However, this procedure gave triene 27 in only 20% yield with complete isomerisation
53. Mee S.P.H., Lee V., and Baldwin J.E. Angew. Chem., Int. Ed. 43 (2004) 1132-1136
54. Mee S.P.H., Lee V., and Baldwin J.E. Chem.-Eur. J. 11 (2005) 3294-3308
55. Harrowven D.C., and Guy I.L. Chem. Commun. (2004) 1968-1969
56. For an excellent review, see:. Seco J.M., Quinoa E., and Riguera R. Chem. Rev. 104 (2004) 17-117
57. A range of conditions were investigated for the direct conversion of ester I (R=Me) into the required primary amide II but without success. With acid I (R=H) a number of peptide coupling procedures were explored, the most promising of which utilised HATU in THF (83%), HBTU (69%) and EDCI·HCl/HOBt (29%).{A figure is presented}
58. Corey E.J., and Eckrick T.M. Tetrahedron Lett. 25 (1984) 2415-2418
59. (See also:. Jung M.E., and Light L.A. Tetrahedron Lett. 23 (1982) 3851-3854 )
60. Ley S.V., Norman J., Griffith W.P., and Marsden S.P. Synthesis (1994) 639-666
61. Franci X., Martina S.L.X., McGrady J.E., Webb M.R., Donald C., and Taylor R.J.K. Tetrahedron Lett. 44 (2003) 7735-7740
62. The ease with which aldehyde Z,Z-16 undergoes isomerisation meant that this modified approach could not be employed to prepare inthomycin A.
63. Itsuno S., Watanabe K., Matsumoto T., Kuroda S., Yokoi A., and El-Shehawy A. J. Chem. Soc., Perkin Trans. 1 (1999) 2011-2016
64. Evans D.A., Gage J.R., and Leighton J.L. J. Am. Chem. Soc. 114 (1992) 9434-9453